<DOC>
<DOCNO>
EP-0003069
</DOCNO>
<TEXT>
<DATE>
19790725
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/19 C12P-17/06 C07D-309/10 A61P-31/00 C12R-1/39 <main>C12P-17/06</main> A61K-31/23 C12P-17/02 C07D-309/00 A61K-31/351 A61K-31/35 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them.
</TITLE>
<APPLICANT>
beecham group ltdgb<sep>beecham group limited<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc<sep>
</APPLICANT>
<INVENTOR>
o'hanlon peter john<sep>rogers norman harold<sep>o'hanlon, peter john<sep>rogers, norman harold<sep>o'hanlon, peter john33 gatton park roadredhill surreygb<sep>rogers, norman harold6 the martsrudgwick sussexgb<sep>o'hanlon, peter john  <sep>rogers, norman harold<sep>o'hanlon, peter john33 gatton park roadredhill surreygb<sep>rogers, norman harold6 the martsrudgwick sussexgb<sep>
</INVENTOR>
<ABSTRACT>
a compound of formula (ii), named pseudomonic acid c  or a salt or ester thereof:    has antibacterial and anti-mycoplasma activity, and can be  produced either by fermentation of pseudomonas fluorescens,  or by de-oxygenation of pseudomonic acid a, the  compound having an epoxide in place of the double bond.   the compounds are therefore useful in the treatment of  human and veterinary bacterial and mycoplasma-induced  infections.  
</ABSTRACT>
</TEXT>
</DOC>
